Joint Formulary & PAD

Teplizumab - Type 1 Diabetes

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous infusion
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Teplizumab
Indication :
Type 1 Diabetes
Group Name :
Keywords :
Brand Names Include :
Tzield
Important Information :

For delaying the onset of stage 3 Type 1 diabetes in line with NICE TA1176

Latest Additions Date From :
01 Sep 2026
Latest Additions Date To :
30 Oct 2026
Guidelines :
Supporting Documents :
1

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Teplizumab is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Type 1 Diabetes.